Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
Clinical trial NCT07680088 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07680088
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-09-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.